Research reveals how herpes simplex virus-1 may contribute to Alzheimer’s disease, offering new insights into the disease’s ...

A new blood test may be key to uncovering new Alzheimer's disease therapies, allowing patients to be treated before the ...

Recent studies implicate the immune system and a herpes virus as potential contributors to development of disease ...

Investors seeking the next obesity-like market opportunity will be closely watching developments related to treatments for ...

Anavex Life Sciences' Blarcamesine trial raises concerns over approval. Learn why AVXL stock is undervalued, reflecting the ...

"During the early stage, it's possible for people with dementia to live well by taking control of their health and wellness, ...

Alzheimer’s drugs could unlock a $13 billion market by 2030, with Biogen, Eli Lilly, Novo Nordisk, Roche, and UCB leading the ...

A groundbreaking study reveals that concussions and repetitive head injuries in sports could trigger latent viruses in the ...

Aging involves gradual functional decline across various biological systems, including impaired cellular mechanisms such as ...

The study reveals a potential link between concussions and the activation of dormant viruses, which may lead to ...

Declining blood levels of two molecules that occur naturally in the body track closely with worsening Alzheimer's disease, particularly in women. Levels were found to drop gradually, from women with ...

HSV-1 is a common virus. During infection, its DNA incorporates into host chromosomes, where it lies dormant. An estimated two-thirds of adults worldwide carry these latent HSV-1 genes. Previous work ...